Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases... Show more
Industry MedicalSpecialties
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GUNR | 40.23 | 0.61 | +1.54% |
| FlexShares Mstar Glbl Upstrm Nat Res ETF | |||
| PID | 20.38 | 0.28 | +1.39% |
| Invesco International Div Achiev ETF | |||
| MYLD | 23.25 | 0.28 | +1.22% |
| Cambria Micro and Smcp Shld Yld ETF | |||
| BGH | 15.34 | 0.13 | +0.85% |
| Barings Global Short Duration High Yield Fund | |||
| EALT | 32.56 | -0.02 | -0.07% |
| Innovator U.S. Equity 5 To 15 Buf ETF-Qt | |||
A.I.dvisor tells us that NVYTF and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVYTF and ARAY's prices will move in lockstep.
| Ticker / NAME | Correlation To NVYTF | 1D Price Change % | ||
|---|---|---|---|---|
| NVYTF | 100% | N/A | ||
| ARAY - NVYTF | 31% Poorly correlated | -1.49% | ||
| MBGNF - NVYTF | 28% Poorly correlated | N/A | ||
| PRCT - NVYTF | 21% Poorly correlated | +0.70% | ||
| PCHM - NVYTF | 7% Poorly correlated | N/A | ||
| POCI - NVYTF | 3% Poorly correlated | N/A | ||
More | ||||